ATLASInterCure (INCR) earnings date: expected December 28 – January 3
InterCure (INCR) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around December 28 – January 3. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INCR
| Last price | $4.10 (+3.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.9% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the InterCure stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around December 28 – January 3 (estimate). One email the day before, with ATLAS’s read on InterCure. You can switch it off at any time.
Alert me before INCR reportsFree to start. Creating an account takes under a minute.
Notify me when InterCure reports
Track INCR free Add InterCure to a free ATLAS watchlist and see its next report date in one place.
INCR earnings at a glance
| Next report | Not announced · expected around December 28 – January 3 (ATLAS estimate) |
|---|---|
| Last report | Jul 22, 2026 · In line |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | +6.3% |
| Average move around a report | ±4.4% (last 5) |
| Sector | Healthcare · Drug Manufacturers - Specialty & Generic |
The expected window is an ATLAS estimate: it takes the typical gap between InterCure’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
InterCure earnings history: last 5 reports
InterCure last reported on Jul 22, 2026: EPS of $0.07 against an estimate of $0.07 (0.0% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 22, 2026 | $0.07 | $0.07 | 0.0% | In line | +5.1% |
| Jun 24, 2026 | -$0.02 | -$0.02 | 0.0% | In line | -5.5% |
| May 5, 2026 | $2.88 | $3.30 | +14.6% | Beat | +6.7% |
| Feb 11, 2026 | $2.08 | $2.10 | +1.0% | In line | -3.2% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | +1.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INCR
See the fair value, the probability range and the earnings history of InterCure on its ATLAS page.
InterCure (INCR) stock analysisPlans from €3.99 a month.
InterCure earnings: frequently asked questions
When is InterCure (INCR) next earnings date?
InterCure has not announced its next report. Its last 3 reports came Jul 22, 2026, May 5, 2026, Feb 11, 2026, so ATLAS estimates the next one around December 28 – January 3. This is an estimate based on that pattern, not a confirmed date.
How often does INCR beat earnings estimates?
Of its last 5 reports with a recorded result, InterCure beat the EPS estimate 2 times; the average surprise was +6.3%. Past results do not predict the next one.
How much does INCR move around earnings?
Over its last 5 reports the stock moved an average of 4.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did InterCure beat earnings estimates last quarter?
InterCure last reported on Jul 22, 2026: EPS of $0.07 against an estimate of $0.07 (0.0% surprise), in line with the estimate.
How much does INCR usually move in a day?
On a normal trading day the ATLAS model puts INCR’s one-day range at about ±9.9%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer